147 related articles for article (PubMed ID: 8797048)
1. High-affinity anti-DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus.
Funauchi M; Ikoma S; Enomoto H; Ohno M; Kinoshita K; Horiuchi A; Kurata N
Intern Med; 1996 May; 35(5):367-72. PubMed ID: 8797048
[TBL] [Abstract][Full Text] [Related]
2. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
3. Combination of immunoadsorption therapy and high-dose methylprednisolone in patients with lupus nephritis; possible indications in patients with early stage.
Funauchi M; Ikoma S; Imada A; Kanamaru A
J Clin Lab Immunol; 1997; 49(2):47-57. PubMed ID: 9819673
[TBL] [Abstract][Full Text] [Related]
4. The course of anticardiolipin antibody levels under immunoadsorption therapy.
Hauser AC; Hauser L; Pabinger-Fasching I; Quehenberger P; Derfler K; Hörl WH
Am J Kidney Dis; 2005 Sep; 46(3):446-54. PubMed ID: 16129206
[TBL] [Abstract][Full Text] [Related]
5. Immune recognition of DNA in SLE.
Pisetsky DS
Clin Immunol Immunopathol; 1998 Jan; 86(1):1-2. PubMed ID: 9434790
[No Abstract] [Full Text] [Related]
6. Immunoadsorption in SLE: three different high affinity columns are adequately effective in removing autoantibodies and controlling disease activity.
Biesenbach P; Schmaldienst S; Smolen JS; Hörl WH; Derfler K; Stummvoll GH
Atheroscler Suppl; 2009 Dec; 10(5):114-21. PubMed ID: 20129388
[TBL] [Abstract][Full Text] [Related]
7. Anti-DNA and anti-nucleosome antibody affinity--a mirror image of lupus nephritis?
Williams RC; Malone C; Blood B; Silvestris F
J Rheumatol; 1999 Feb; 26(2):331-46. PubMed ID: 9972967
[TBL] [Abstract][Full Text] [Related]
8. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
9. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
10. Selective absorption of anti-DNA antibodies and their idiotype-positive cells in vitro using an anti-idiotypic antibody-affinity column: possible application to plasma exchange.
Harata N; Sasaki T; Shibata S; Kameoka J; Hirabayashi Y; Osaki H; Tamate E; Yoshinaga K
J Clin Apher; 1991; 6(1):34-9. PubMed ID: 2045381
[TBL] [Abstract][Full Text] [Related]
11. Up regulation of serum tumor necrosis factor-related apoptosis inducing ligand in juvenile-onset systemic lupus erythematosus: relations with disease activity, antibodies to double -stranded DNA, nephritis and neutropenia.
Ezzat MH; El-Gammasy TM; Shaheen KY; El-Mezdawi RA; Youssef MS
Int J Rheum Dis; 2013 Jun; 16(3):310-8. PubMed ID: 23981753
[TBL] [Abstract][Full Text] [Related]
12. Are the clonotypes of serum IgG anti-DNA antibodies associated with lupus nephritis in humans?
Hatakeyama A; Sasaki T; Muryoi T; Murai C; Yoshinaga K
J Clin Lab Immunol; 1990 Feb; 31(2):93-7. PubMed ID: 1966991
[TBL] [Abstract][Full Text] [Related]
13. High-avidity anti-DNA antibody removal from the serum of systemic lupus erythematosus patients by adsorption using dextran sulfate cellulose columns.
Matsuki Y; Suzuki K; Kawakami M; Ishizuka T; Kawaguchi Y; Hidaka T; Nakamura H
J Clin Apher; 1996; 11(1):30-5. PubMed ID: 8722720
[TBL] [Abstract][Full Text] [Related]
14. A surge in anti-dsDNA titer predicts a severe lupus flare within six months.
Pan N; Amigues I; Lyman S; Duculan R; Aziz F; Crow MK; Kirou KA
Lupus; 2014 Mar; 23(3):293-8. PubMed ID: 24316605
[TBL] [Abstract][Full Text] [Related]
15. Serial studies of the IgG subclass and functional affinity of DNA antibodies in systemic lupus erythematosus.
Devey ME; Lee SR; Le Page S; Feldman R; Isenberg DA
J Autoimmun; 1988 Oct; 1(5):483-94. PubMed ID: 3075912
[TBL] [Abstract][Full Text] [Related]
16. Idiotypic vaccination with a murine anti-dsDNA antibody: phase I study in patients with nonactive systemic lupus erythematosus with nephritis.
Spertini F; Leimgruber A; Morel B; Khazaeli MB; Yamamoto K; Dayer JM; Weisbart RH; Lee ML
J Rheumatol; 1999 Dec; 26(12):2602-8. PubMed ID: 10606369
[TBL] [Abstract][Full Text] [Related]
17. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
Suzuki N; Harada T; Mizushima Y; Sakane T
J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
[TBL] [Abstract][Full Text] [Related]
18. Is closer linkage between systemic lupus erythematosus and anti-double-stranded DNA antibodies a desirable and attainable goal?
Nossent HC; Rekvig OP
Arthritis Res Ther; 2005; 7(2):85-7. PubMed ID: 15743494
[TBL] [Abstract][Full Text] [Related]
19. The role of antibodies to DNA in systemic lupus erythematosus--a review and introduction to an international workshop on DNA antibodies held in London, May 1996.
Isenberg DA; Ravirajan CT; Rahman A; Kalsi J
Lupus; 1997; 6(3):290-304. PubMed ID: 9296771
[No Abstract] [Full Text] [Related]
20. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
